218
Views
8
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Efficacy and acceptability of oxcarbazepine vs. carbamazepine with betahistine mesilate tablets in treating vestibular paroxysmia: a retrospective review

, , , , , & show all
Pages 492-495 | Received 25 Feb 2016, Accepted 30 Mar 2016, Published online: 18 Apr 2016

References

  • Jannetta PJ. Neurovascular cross-compression in patients with hyperactive dysfunction symptoms of the eighth cranial nerve. Surg Forum. 1975;26:467–469.
  • Brandt T, Dieterich M. Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet. 1994;343(8900):798–799.
  • Hüfner K, Barresi D, Glaser M, et al. Vestibular paroxysmia: diagnostic features and medical treatment. Neurology. 2008;71(13):1006–1014.
  • Strupp M, Brandt T. Peripheral vestibular disorders. Curr Opin Neurol. 2013;26(1):81–89.
  • Brandt T, Huppert T, Hüfner K, et al. Long-term course and relapses of vestibular and balance disorders. Restor Neurol Neurosci. 2010;28(1):69–82.
  • Brandt T, Zwergal A, Strupp M. Medical treatment of vestibular disorders. Expert Opin Pharmacother. 2009;10:1537–1548.
  • Møller MB, Møller AR, Jannetta PJ, et al. Microvascular decompression of the eighth nerve in patients with disabling positional vertigo: selection criteria and operative results in 207 patients. Acta Neurochir (Wien). 1993;125(1–4):75–82.
  • Li J-H. Efficacy of carbamazepine combined with mestilate in treatment of vestibular paroxysmia. Chin J Trauma Disabil Med. 2013;21(10):41–42.
  • Chen Y, Zhao Z, Zhuang J, et al. The efficiency of carbamazepine in treatment of vestibular paroxysmia. J Apoplexy Nervous Diseases. 2011;28(3):242–243.
  • Hai-long X, Cuang-xia L, Wen X, et al. Comparative efficacy of oxcarbazepine versus carbamazepine in treating vestibular paroxysmia. J Apoplexy Nervous Dis. 2015;32(9):829.
  • Russell D, Baloh RW. Gabapentin responsive audiovestibular paroxysmia. J Neurol Sci. 2009;281(1):99–100.
  • Zakrzewska JM, McMillan R. Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain. Postgrad Med J. 2011;87(1028):410–416.
  • Wang Q, Bai M. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia. CNS Drugs. 2011;25(10):847.
  • Jannetta PJ, Møller MB, Møller AR. Disabling positional vertigo. New England J Med. 1984;310(26):1700–1705.
  • Møller AR. Vascular compression of cranial nerves. I. History of the microvascular decompression operation. Neurol Res. 1998;20(8):727–731.
  • Kuroki A, Møller AR. Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats. Acta Neurochir (Wien). 1994;126(2–4):149–157.
  • Marcel C, Anheim M, Flamand-Rouviere C, et al. Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases. J Neurol. 2010;257(8):1369–1372.
  • Li Y, Zeng C, Luo T. Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings. J Neurol. 2011;258(2):273–276.
  • Chen J, Zhou C, Liu Z, et al. Divergent urinary metabolic phenotypes between major depressive disorder and bipolar disorder identified by a combined GC–MS and NMR spectroscopic metabonomic approach. J Proteome Res. 2015;14(8):3382–3389.
  • Chen JJ, Huang H, Zhao L, et al. Sex-specific urinary biomarkers for diagnosing bipolar disorder. PloS one. 2014;9(12):e115221.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.